MucoJet: a novel noninvasive buccal mucosa immunization strategy.
作者信息
Munang'andu Hetron Mweemba
机构信息
Department of Basic Sciences and Aquatic Medicine, Norwegian University of Life Sciences, Faculty of Veterinary Medicine and Biosciences, Oslo, Norway.
出版信息
Ann Transl Med. 2018 Feb;6(3):64. doi: 10.21037/atm.2018.01.11.
Abstract
摘要
相似文献
1
MucoJet: a novel noninvasive buccal mucosa immunization strategy.
Ann Transl Med. 2018 Feb;6(3):64. doi: 10.21037/atm.2018.01.11.
2
Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein.
J Immunol. 2001 Jul 1;167(1):384-91. doi: 10.4049/jimmunol.167.1.384.
3
Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits.
Pharm Res. 2002 Jul;19(7):947-53. doi: 10.1023/a:1016454003450.
4
The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo.
Clin Exp Immunol. 1998 Sep;113(3):386-93. doi: 10.1046/j.1365-2249.1998.00671.x.
5
[Use of buccal swab as a source of genomic DNA for genetic screening in patients with age-related macular degeneration].
Zhonghua Yan Ke Za Zhi. 2012 Feb;48(2):114-8.
6
MucoJet: A novel oral microjet vaccination system.
Oral Dis. 2018 Oct;24(7):1145-1147. doi: 10.1111/odi.12697. Epub 2017 Jul 13.
7
Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies.
Cancer Res. 1995 Mar 15;55(6):1267-70.
8
Enabling Noninvasive Systemic Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] via the Buccal Mucosa.
J Pharm Sci. 2016 Jul;105(7):2173-9. doi: 10.1016/j.xphs.2016.05.008. Epub 2016 Jun 13.
9
Microprojection arrays to immunise at mucosal surfaces.
J Control Release. 2014 Dec 28;196:252-60. doi: 10.1016/j.jconrel.2014.09.028. Epub 2014 Oct 5.
10
Human vaginal mucosa as a model of buccal mucosa for in vitro permeability studies: an overview.
Curr Drug Deliv. 2004 Apr;1(2):129-35. doi: 10.2174/1567201043479975.
引用本文的文献
1
Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.
Front Pharmacol. 2022 Jan 11;12:757761. doi: 10.3389/fphar.2021.757761. eCollection 2021.
2
Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems.
Vaccines (Basel). 2021 Oct 14;9(10):1177. doi: 10.3390/vaccines9101177.
本文引用的文献
1
An oral microjet vaccination system elicits antibody production in rabbits.
Sci Transl Med. 2017 Mar 8;9(380). doi: 10.1126/scitranslmed.aaf6413.
2
Novel strategies for the buccal delivery of macromolecules.
Drug Dev Ind Pharm. 2014 May;40(5):579-90. doi: 10.3109/03639045.2014.892960. Epub 2014 Mar 10.
3
Noninvasive routes of proteins and peptides drug delivery.
Indian J Pharm Sci. 2011 Jul;73(4):367-75. doi: 10.4103/0250-474X.95608.
4
Mouse and human intestinal immunity: same ballpark, different players; different rules, same score.
Mucosal Immunol. 2011 Mar;4(2):148-57. doi: 10.1038/mi.2010.85. Epub 2011 Jan 12.
5
Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
J Immunol. 2011 Jan 15;186(2):891-900. doi: 10.4049/jimmunol.1002943. Epub 2010 Dec 15.
6
Terminology: nomenclature of mucosa-associated lymphoid tissue.
Mucosal Immunol. 2008 Jan;1(1):31-7. doi: 10.1038/mi.2007.9.
7
Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers.
J Pharm Sci. 2009 Feb;98(2):471-83. doi: 10.1002/jps.21436.
8
Buccal mucosa as a route for systemic drug delivery: a review.
J Pharm Pharm Sci. 1998 Jan-Apr;1(1):15-30.
9
Mucosal immunity and tolerance: relevance to vaccine development.
Immunol Rev. 1999 Aug;170(1):197-222. doi: 10.1111/j.1600-065x.1999.tb01339.x.
10
The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals.
Trends Biotechnol. 1998 Aug;16(8):343-9. doi: 10.1016/s0167-7799(98)01186-x.
Zotero 插件